Company intelligence / Profile preview
Nuo Therapeutics
Houston, Texas, United Statesnuot.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Commercial
01
Overview
Nuo Therapeutics has commercialized the Aurix System—a point-of-care device that processes a patient’s own blood to create an autologous platelet-rich gel. Clinical results have demonstrated efficacy in accelerating healing of chronic wounds such as diabetic foot ulcers and venous leg ulcers. The product has established value in hospital outpatient settings.
- Therapeutic areas
- DermatologyCardiovascularImmunology
- Modalities
- DeviceBiologic (autologous platelet and plasma-derived therapy)Cell therapy (autologous blood components)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Beyond the preview
Go deeper on Nuo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuo Therapeutics.